Sale!

MYO15A Gene Deafness Autosomal Recessive Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYO15A gene plays a crucial role in the development and maintenance of the inner ear’s structure, which is essential for proper hearing. Mutations in the MYO15A gene can lead to deafness, autosomal recessive type 3, a condition characterized by significant hearing loss from birth. This type of genetic hearing impairment is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

DNA Labs UAE offers a specialized genetic test to identify mutations in the MYO15A gene, providing crucial information for families affected by or at risk of autosomal recessive deafness type 3. The test involves analyzing the individual’s DNA, extracted from a blood sample or cheek swab, to detect any alterations in the MYO15A gene that could lead to the condition.

The cost of the MYO15A gene deafness autosomal recessive type 3 genetic test at DNA Labs UAE is 4400 AED. This test is particularly valuable for prospective parents with a family history of the condition, individuals who have been diagnosed with unexplained hearing loss, and families seeking more information about their genetic health. By identifying the specific genetic cause of deafness, the test can facilitate informed decisions about family planning, early intervention, and management strategies for affected individuals.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYO15A Gene Deafness autosomal recessive type 3 Genetic Test

Are you or your loved ones experiencing profound hearing loss from birth? It could be due to autosomal recessive type 3 (DFNB3) deafness caused by the MYO15A gene. At DNA Labs UAE, we offer a comprehensive genetic test to diagnose this condition.

Test Details

The MYO15A gene is associated with autosomal recessive type 3 (DFNB3) deafness. This genetic condition results in profound hearing loss that is present from birth. To identify any mutations or variations in the MYO15A gene that may be causing the deafness, we utilize NGS (Next-Generation Sequencing) technology. NGS genetic testing allows us to analyze multiple genes simultaneously, providing a comprehensive assessment of the MYO15A gene.

Components

  • Test Name: MYO15A Gene Deafness autosomal recessive type 3 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Prior to the MYO15A Gene Deafness autosomal recessive type 3 Genetic Test, it is recommended to provide the clinical history of the patient who is going for the SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. Additionally, a genetic counseling session is advised to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A9.

Benefits of Genetic Testing

By identifying the specific genetic mutation responsible for MYO15A gene deafness, NGS genetic testing can help in diagnosing individuals with this condition. This information is crucial for genetic counseling and can guide treatment options, such as the use of hearing aids or cochlear implants.

Conclusion

If you or someone you know is experiencing profound hearing loss from birth, our MYO15A Gene Deafness autosomal recessive type 3 Genetic Test can provide valuable insights. With our advanced NGS technology and expertise in genetics, DNA Labs UAE is dedicated to helping individuals and families understand their genetic conditions and make informed decisions about their healthcare.

Test Name MYO15A Gene Deafness autosomal recessive type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A9
Test Details

The MYO15A gene is associated with a specific type of deafness known as autosomal recessive type 3 (DFNB3). This condition is characterized by profound hearing loss that is present from birth.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be responsible for a specific condition. In the case of MYO15A gene deafness, an NGS genetic test would involve sequencing the MYO15A gene to identify any mutations or variations that may be causing the autosomal recessive type 3 deafness.

By identifying the specific genetic mutation responsible for the condition, NGS genetic testing can help in diagnosing individuals with MYO15A gene deafness. This information can also be used for genetic counseling and to guide treatment options, such as the use of hearing aids or cochlear implants.